Sun Pharma, Aurobindo Pharma, other stocks in focus as Trump exempts India from 100% tariffs on some speciality drugs

The US has exempted India, along with 19 other countries, from 100% tariffs on certain patented specialty pharmaceuticals and ingredients. This move is significant for Indian pharma stocks, including Sun Pharma and Aurobindo Pharma, as it could boost their exports to the US. The exemption applies to rare-disease drugs, gene and cell therapies, and infertility treatments, which are typically high-value and high-margin products. This development is likely to have a positive impact on the Indian pharma sector, particularly for companies that export these types of medicines to the US.

Why it matters

The US has exempted India from 100% tariffs on some speciality drugs. This could increase demand for Indian pharma products and boost their exports.

Market impact

Markets & countries in focus

Transmission channels

Likely winners & losers

Explore the intelligence

MeridStreet does not reproduce source articles. The summary and analysis above are generated by MeridStreet from public headlines and its own market model; the original reporting belongs to Economic Times. For information only — not financial advice.